If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend King
Abbott Laboratories (ABT) is highlighted as a potential safe haven in case of a stock market crash, given its status as a Dividend King with 54 consecutive years of dividend increases. The company reported Q2 sales of $12.6B, up 13% YoY, and raised its full-year EPS forecast. Abbott's dividend payout ratio is 46%, and it returned $2.1B to shareholders in Q2. Growth is expected to accelerate in 2026, driven by new products and the $21B acquisition of Exact Sciences. Analysts rate ABT as a strong
How this was made
The 30-second read
Why it matters
Abbott's earnings beat and raised guidance suggest continued dividend sustainability and growth potential.
Market read
Earnings beat and guidance raise expectations for ABT, influencing dividend‑seeking investors.
What to watch
Potential integration risk from the Exact Sciences acquisition.
Background
The article discusses Abbott Laboratories as a Dividend King and its recent earnings performance.
Ticker impact
Abbott reported Q2 sales of $12.6B, EPS $1.31 beating expectations and raised FY EPS guidance to $5.45‑$5.60.
Potential upside of 3‑5% in the near term as investors price in higher earnings.
Quarterly beat and upward guidance are fresh, material data for a large cap.
Market effects
Positive earnings may lift the broader healthcare equipment sector.
U.S. market may see modest gains in dividend‑focused funds.
Limited to investors tracking dividend kings and healthcare stocks.
Counterpoint
Higher guidance could be offset by valuation concerns if the stock is already priced in.
Key entities
- companyAbbott Laboratories
U.S. healthcare company and Dividend King.
